Pfizer Inc.’s proposed $160 billion merger with Allergan plc fizzled dramatically on Wednesday, after months of public anger and regulatory angst over the controversial tax inversion deal.
So why should Pfizer be thanking its lawyers?
The demise of a controversial tax inversion deal with Allergan may have frustrated Pfizer, but it doesn't leave the U.S. drug giant that much poorer.
April 06, 2016 at 08:27 PM
1 minute read
Pfizer Inc.’s proposed $160 billion merger with Allergan plc fizzled dramatically on Wednesday, after months of public anger and regulatory angst over the controversial tax inversion deal.
So why should Pfizer be thanking its lawyers?
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
Honoring outstanding legal achievements focused at the national level, largely around Big Law and in-house departments.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS